Accessibility Menu
Owc Pharmaceutical Research logo

Owc Pharmaceutical Research(OTC) OWCP

Market Cap$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Owc Pharmaceutical Research last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-31
Owc Pharmaceutical Research stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-21
1 month+0%USD 0.002026-06-30
3 month+0%USD 0.002026-04-27
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-07-23
3 year+0%USD 0.002023-07-21
5 year-99.99%USD 0.012021-07-30
Since inception-100%USD 19.002009-03-19

Owc Pharmaceutical Research Financials at a Glance

Market Cap

$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$1.34M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-85.50 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.28

Estimated Earnings Date

N/A

OWCP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Owc Pharmaceutical Research

OWC Pharmaceutical Research Corp. is a company focused on the research and development of cannabis-based medical products. Operating through its subsidiary, One World Cannabis Ltd., the company aims to create therapies for various conditions, including multiple myeloma and PTSD.

Products and Services
  • Research and development of cannabis-derived therapies
  • Consulting services on medical cannabis protocols
  • Innovative cannabis soluble tablet delivery system
Growth Outlook
  • Expanding market for cannabis-based therapies presents significant opportunities
  • Increased global acceptance of medical cannabis enhances potential customer base
  • Focus on innovative delivery systems may lead to competitive advantages
Financial Highlights
  • Recent quarterly net income of -$287,000 indicates ongoing investment in R&D
  • Cash and cash equivalents of $1,465,000 provide liquidity for operations
  • Current ratio of 8.03 suggests strong short-term financial health
OWC Pharmaceutical Research Corp. operates in the healthcare sector, specifically within the drug manufacturing industry. The company is dedicated to developing innovative cannabis-based therapies, which are increasingly recognized for their potential benefits in treating various medical conditions. The focus on research and development, along with consulting services, positions OWC Pharmaceutical as a key player in the evolving landscape of medical cannabis. The growth outlook for the company is promising, driven by the expanding market for cannabis-based therapies and the increasing global acceptance of medical cannabis. The innovative delivery systems being developed may also provide a competitive edge in the market. Financially, the company has shown resilience despite reporting a net loss in recent quarters. The liquidity position, with cash and cash equivalents of $1,465,000, supports ongoing operations and research initiatives. The strong current ratio further indicates that the company is well-positioned to meet its short-term obligations. Overall, OWC Pharmaceutical Research Corp. presents an intriguing opportunity for investors interested in the burgeoning field of medical cannabis.
AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Ramat Gan, TA 5257334, IL

OWCP Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

237.20%

Return on Capital

N/A

Return on Assets

-288.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

497.50M

Volume

1.00K

Avg. Volume

4.32K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$12.28M

EBITDA

-$7.26M

Operating Cash Flow

-$2.74M

Capital Expenditure

-$7.04K

Free Cash Flow

-$2.75M

Cash & ST Invst.

$1.47M

Total Debt

$47.00K

Owc Pharmaceutical Research Performance Analysis

Owc Pharmaceutical Research sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42018-12-31N/A
Q12019-03-31N/A
Q22019-06-30N/A
Q32019-09-30N/A
Owc Pharmaceutical Research sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42018-12-31-411.9%
Q12019-03-3181.9%
Q22019-06-3059.7%
Q32019-09-3052.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2019YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$55.56

N/A

Employees

9

N/A

Net Income

-$287.00K

+71.0%

EBITDA

-$685.00K

-2.7%

Quarterly Fundamentals

Name
Q3 2019YOY CHG

Total Cash

$1.47M

-65.3%

Total Debt

$47.00K

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$21.00K

N/A

Short Term Debt

$52.00K

N/A

Return on Assets

-2.89%

N/A

Return on Invested Capital

-1.38%

N/A

Free Cash Flow

-$372.00K

+13.4%

Operating Cash Flow

-$372.00K

+12.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ISOLFIsodiol International Inc.
$0.00+0.00%
ARYXARYx Therapeutics, Inc.
$0.00+0.00%
NUNZNunzia Pharmaceutical Company
$0.00+0.00%
HENCHero Technologies Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About OWCP

What is the current price of Owc Pharmaceutical Research?

Owc Pharmaceutical Research is trading at $0.00 per share.

What is the 52-week range for Owc Pharmaceutical Research?

Over the past 52 weeks, Owc Pharmaceutical Research has traded between $0.00 and $0.28.

How much debt does Owc Pharmaceutical Research have?

Owc Pharmaceutical Research total debt is unavailable.

How much cash does Owc Pharmaceutical Research have on hand?

Owc Pharmaceutical Research does not have cash on hand data available.

What is Owc Pharmaceutical Research’s dividend yield?

Owc Pharmaceutical Research does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services